For more information contact:
Floyd Wood, IBB
Contact Floyd Wood floyd.wood@ibb.gatech.edu
Embryonic Stem Cells Used on Human
Atlanta (October 11, 2010) — ATLANTA - For the very first time, embryonic stem cells are being used on a human with a spinal cord injury and it’s happening at Shepherd Center in Atlanta.
It’s the first study approved by the Food and Drug Administration to test the controversial therapy.
Some are calling it a major breakthrough in medicine using embryonic stem cells.
But there are others who say there is no need to use embryonic stem cells when adult stem cells have been proven to work.
Inside Shepherd Center a patient, paralyzed with a spinal cord injury, is hoping that a procedure using embryonic stem cells will help.
The patient is the first ever to be injected with millions of embryonic stem cells.
"This is a huge landmark in the field,” said Dr. Todd McDevitt, a stem cell engineer at Georgia Tech.
Read Full Article
The Georgia Institute of Technology is one of the nation's premier research universities. Ranked seventh among U.S. News & World Report's top public universities, Georgia Tech's more than 20,000 students are enrolled in its Colleges of Architecture, Computing, Engineering, Liberal Arts, Management and Sciences. Tech is among the nation's top producers of women and minority engineers. The Institute offers research opportunities to both undergraduate and graduate students and is home to more than 100 interdisciplinary units plus the Georgia Tech Research Institute.
